Oncotelic Therapeutics, Inc. (OTLC) Operating income 2017–2025
Oncotelic Therapeutics, Inc. (OTLC) annual operating income history from SEC filings — each fiscal year as reported.
-$3.2MFY2025 · since FY2017: -$13.8M → -$3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.2M | +10.9% |
| FY2024 | -$3.6M | +46.2% |
| FY2023 | -$6.6M | +31.6% |
| FY2022 | -$9.7M | -6.5% |
| FY2021 | -$9.1M | -20.3% |
| FY2020 | -$7.6M | -75.9% |
| FY2019 | -$4.3M | -504.8% |
| FY2018 | -$712,738 | +94.9% |
| FY2017 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice